Related Experiment Video
Updated: Aug 9, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial fibrillation - patients at high risk for cerebral embolism
P Bernhardt1, H Schmidt, T Sommer
1Department of Medicine-Cardiology, University of Bonn, Germany. bernhardt@cardiovasc-mri.com
Insights
Patients with atrial fibrillation (AF) face a high risk of cerebral embolism, even with oral anticoagulation. Echocardiographic factors like left atrial thrombi identify those needing closer monitoring for embolic events.
Area of Science:
- Cardiology
- Neurology
- Radiology
Background:
- Atrial fibrillation (AF) patients have a significant risk of cerebral embolism.
- Echocardiographic parameters are known risk factors, but long-term silent embolism rates under anticoagulation are unclear.
Purpose of the Study:
- To assess the prognosis of AF patients.
- To identify high-risk groups for cerebral embolism during oral anticoagulation.
- To evaluate the rate of clinically silent cerebral embolism.
Main Methods:
- 128 patients with AF and echocardiographic risk factors (left atrial thrombi, dense spontaneous echo contrast, reduced LA appendage emptying velocities) were studied.
- 114 AF patients without these risk factors served as controls.
- All patients underwent transesophageal echocardiography, cranial MRI, and clinical assessment over three years.
Main Results:
- In the high-risk group, 5% experienced clinically apparent cerebral embolism, and 13% had silent embolism detected by MRI over three years.
- The overall embolic event rate in the high-risk group was 21%.
- Previous thromboembolism was a significant predictor of embolic events.
Conclusions:
- Persistent or permanent AF with specific echocardiographic findings indicates a substantially increased risk of cerebral embolism (21%) despite oral anticoagulation.
- Previous thromboembolic events are a critical predictor for future embolic events in AF patients.
Objective:
Patients with atrial fibrillation (AF) have a risk of cerebral embolism. Echocardiographic parameters elevate this risk significantly. However, there is little knowledge about the long-term fate and the rate of clinically silent cerebral embolism under continued oral anticoagulation. The aims of our study were to assess prognosis of patients with AF and determine a high risk group with an increased risk of cerebral embolism under oral anticoagulation.
Methods:
Consecutive patients with persistent or permanent AF and left atrial (LA) thrombi, dense spontaneous echo contrast (SEC) and/or reduced LA appendage peak emptying velocities (LAAv) were included in the study (N = 128). Patients with AF and without echocardiographic risk factors (N = 114) served as controls. All patients were examined with transesophageal echocardiography, cranial magnetic resonance imaging and clinically during a period of three years.
Results:
During the three-year follow-up period 6 (5%) of the high risk patients had cerebral embolism with neurological deficits. 4 (3%) patients died due to embolic events and 17 (13%) patients had silent embolism as documented on MRI. In the control group 8 (7%) patients had embolic events (n = 1 clinically apparent and n = 7 silent embolism) documented on MRI, one was clinically apparent. Study patients with an event had more commonly previous thromboembolism (p < 0.0001).
Conclusions:
Patients with peristent or permanent AF and LA thrombi, dense SEC or reduced LAAv have an explicitly increased risk of cerebral embolism (21%) despite oral anticoagulation. Previous thromboembolic event is another important predictor for an event.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
